Regeneron to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2025
Regeneron Pharmaceuticals (NASDAQ: REGN) has scheduled its second quarter 2025 financial and operating results announcement for Friday, August 1, 2025, before U.S. markets open. The company will host a conference call and webcast at 8:30 AM Eastern Time on the same day.
Investors can access the conference call through a webcast on Regeneron's investor relations website. Telephone participants must pre-register to receive dial-in details. A replay and transcript will be available on the company's website for at least 30 days after the event.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha programmato la pubblicazione dei risultati finanziari e operativi del secondo trimestre 2025 per il venerd矛 1 agosto 2025, prima dell'apertura dei mercati statunitensi. La societ脿 terr脿 una conference call e una webcast alle 8:30 AM ora della costa orientale dello stesso giorno.
Gli investitori potranno seguire la conference call tramite una webcast sul sito web delle relazioni con gli investitori di Regeneron. I partecipanti telefonici devono preregistrarsi per ricevere i dettagli di accesso. Una registrazione e la trascrizione saranno disponibili sul sito aziendale per almeno 30 giorni dopo l'evento.
Regeneron Pharmaceuticals (NASDAQ: REGN) ha programado el anuncio de sus resultados financieros y operativos del segundo trimestre de 2025 para el viernes 1 de agosto de 2025, antes de la apertura de los mercados de EE.UU. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n en vivo a las 8:30 AM hora del Este ese mismo d铆a.
Los inversores podr谩n acceder a la llamada conferencia mediante una transmisi贸n en vivo en el sitio web de relaciones con inversores de Regeneron. Los participantes por tel茅fono deben preregistrarse para recibir los detalles de acceso. Una grabaci贸n y la transcripci贸n estar谩n disponibles en el sitio web de la compa帽铆a durante al menos 30 d铆as despu茅s del evento.
Regeneron Pharmaceuticals (NASDAQ: REGN)電� 2025雲� 2攵勱赴 鞛 氚� 鞖挫榿 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 1鞚� 旮堨殧鞚� 氙戈淡 鞁滌灔 臧滌灔 鞝勳溂搿� 鞓堨爼頄堨姷雼堧嫟. 須岇偓電� 臧欖潃 雮� 霃欕秬 響滌鞁� 鞓れ爠 8鞁� 30攵�鞐� 旎嵓霟办姢 旖滉臣 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
韴瀽鞛愲摛鞚� Regeneron 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 旎嵓霟办姢 旖� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟. 鞝勴檾 彀胳棳鞛愲姅 鞝勴檾 鞝戩啀 鞝曤炒毳� 氚涥赴 鞙勴暣 靷爠 霌彪頃挫暭 頃╇媹雼�. 雲轨潓 氚� 鞝勳偓氤胳潃 頄夓偓 頉� 斓滌唽 30鞚缄皠 須岇偓 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅╇媹雼�.
Regeneron Pharmaceuticals (NASDAQ : REGN) a programm茅 l'annonce de ses r茅sultats financiers et op茅rationnels du deuxi猫me trimestre 2025 pour le vendredi 1er ao没t 2025, avant l'ouverture des march茅s am茅ricains. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une webcast 脿 8h30, heure de l'Est, le m锚me jour.
Les investisseurs pourront acc茅der 脿 la conf茅rence t茅l茅phonique via une webcast sur le site des relations investisseurs de Regeneron. Les participants par t茅l茅phone doivent s'inscrire au pr茅alable pour recevoir les informations de connexion. Une rediffusion et une transcription seront disponibles sur le site de la soci茅t茅 pendant au moins 30 jours apr猫s l'茅v茅nement.
Regeneron Pharmaceuticals (NASDAQ: REGN) hat die Bekanntgabe der Finanz- und Betriebsergebnisse f眉r das zweite Quartal 2025 f眉r Freitag, den 1. August 2025, vor 脰ffnung der US-M盲rkte, geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Telefonkonferenz und Webcast veranstalten.
Investoren k枚nnen 眉ber einen Webcast auf der Investor-Relations-Website von Regeneron an der Telefonkonferenz teilnehmen. Telefonische Teilnehmer m眉ssen sich vorab registrieren, um die Einwahldaten zu erhalten. Eine Aufzeichnung und das Transkript werden f眉r mindestens 30 Tage nach der Veranstaltung auf der Website des Unternehmens verf眉gbar sein.
- None.
- None.
TARRYTOWN, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2025 financial and operating results on Friday, August 1, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.
Conference Call Information
Participants may access the conference call live via webcast on the 鈥橧nvestors and Media鈥� page of Regeneron鈥檚 website at . To participate via telephone, please register in advance at this . Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay and transcript of the conference call and webcast will be archived on the Company鈥檚 website for at least 30 days.
About Regeneron
搁别驳别苍别谤辞苍听(狈础厂顿础蚕: REGN) is a leading biotechnology company that invents,听develops听and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to听repeatedly and consistently translate science听into medicine has led to numerous approved treatments and鈥痯roduct candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious听diseases, and rare diseases.听
Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as VelociSuite庐, which produces optimized fully human antibodies and new classes of bispecific antibodies.鈥疻e are shaping the next frontier of medicine with data-powered insights from the鈥疪egeneron Genetics Center庐鈥痑nd pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.
For more information, please visit or follow Regeneron on , , or .
| Contact Information:听 听听 | 听 | 听 |
| Investor Relations | 听 | Corporate Communications |
| Ryan Crowe | 听 | Christina Chan |
| 914.847.8790 | 听 | 914.847.8827 |
| [email protected] | 听 | [email protected] |
FAQ
When will Regeneron (REGN) report Q2 2025 earnings?
What time is Regeneron's Q2 2025 earnings call?
How can investors access Regeneron's Q2 2025 earnings call?
How long will Regeneron's Q2 2025 earnings call replay be available?
